Cargando…

Patterns and predictors of statin prescription in patients with type 2 diabetes

BACKGROUND: The benefit of statins for prevention of cardiovascular events in type 2 diabetes is established, but a gap exists between guideline recommendations and clinical practice. The aim of the study was to identify patient-related factors predicting statin prescription. METHODS: We assessed th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berthold, Heiner K, Gouni-Berthold, Ioanna, Böhm, Michael, Krone, Wilhelm, Bestehorn, Kurt P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689197/ https://www.ncbi.nlm.nih.gov/pubmed/19439071 http://dx.doi.org/10.1186/1475-2840-8-25

Ejemplares similares

Sex Disparities in the Treatment and Control of Cardiovascular Risk Factors in Type 2 Diabetes
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2008)

Association between the Interleukin-6 Promoter Polymorphism −174G/C and Serum Lipoprotein(a) Concentrations in Humans
por: Berthold, Heiner K., et al.
Publicado: (2011)

Effects of Lipid-Lowering Drugs on High-Density Lipoprotein Subclasses in Healthy Men—A Randomized Trial
por: Berthold, Heiner K., et al.
Publicado: (2014)

Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2013)

PCSK9 Antibodies for the Treatment of Hypercholesterolemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2014)

PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid–Based Therapy Era
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2022)

Updates in Drug Treatment of Severe Hypertriglyceridemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2023)

Evidence from a Randomized Trial That Simvastatin, but Not Ezetimibe, Upregulates Circulating PCSK9 Levels
por: Berthold, Heiner K., et al.
Publicado: (2013)

Significant Quality of Life Improvement Observed in a Patient With FCS Associated With a Marked Reduction in Triglycerides
por: Gouni-Berthold, Ioanna
Publicado: (2019)

A 3 year post‐intervention follow‐up on mortality in advanced heart failure (EVITA vitamin D supplementation trial)
por: Zittermann, Armin, et al.
Publicado: (2020)

PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects
por: Katzmann, Julius L., et al.
Publicado: (2020)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Statin Prescription Patterns and Associations with Subclinical Inflammation
por: Kadappu, Preetham, et al.
Publicado: (2022)

Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin and PCSK9 Deficiency
por: Tarasov, Kirill, et al.
Publicado: (2014)

Anti‐PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care
por: Descamps, Olivier S., et al.
Publicado: (2017)

Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2
por: Gupta, Rajeev, et al.
Publicado: (2016)

Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy
por: Chung, Yoo-Ri, et al.
Publicado: (2017)

Statin Prescription Patterns Among Elderly Patients with Type 2 Diabetes: A Cross-Sectional Study in Lebanon
por: Al Souheil, Farah, et al.
Publicado: (2022)

Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial
por: Zittermann, Armin, et al.
Publicado: (2018)

Statin prescription among patients with type 2 diabetes in Botswana: findings and implications
por: Mwita, Julius Chacha, et al.
Publicado: (2020)

Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany
por: Gitt, Anselm K., et al.
Publicado: (2010)

Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment
por: Howard, James P., et al.
Publicado: (2021)

Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis
por: Dormuth, Colin R, et al.
Publicado: (2008)

A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program
por: Frisch, Sabine, et al.
Publicado: (2009)

Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort
por: Bai, Johnny W., et al.
Publicado: (2016)

Systematic review of published Phase 3 data on anti‐PCSK9 monoclonal antibodies in patients with hypercholesterolaemia
por: Gouni‐Berthold, Ioanna, et al.
Publicado: (2016)

Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study
por: Kim, Ji Yoon, et al.
Publicado: (2022)

Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins
por: Kang, Jeehoon, et al.
Publicado: (2018)

Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2022)

Opioid Prescription Patterns and Risk Factors Associated With Opioid Use in the Netherlands
por: Bedene, Ajda, et al.
Publicado: (2019)

Patterns of Manufacturer Coupon Use for Prescription Drugs in the US, 2017-2019
por: Kang, So-Yeon, et al.
Publicado: (2023)

Patient Preference Distribution for Use of Statin Therapy
por: Brodney, Suzanne, et al.
Publicado: (2021)

Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes
por: Morieri, Mario Luca, et al.
Publicado: (2021)

Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial
por: Chihara, Atsuko, et al.
Publicado: (2019)

Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study
por: Na, Eonji, et al.
Publicado: (2020)

Phytosterols and Cardiovascular Risk Evaluated against the Background of Phytosterolemia Cases—A German Expert Panel Statement †
por: Windler, Eberhard, et al.
Publicado: (2023)

Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry
por: Bestehorn, Kurt, et al.
Publicado: (2009)

Prescription patterns of antidementives in a high income country: A pharmacoepidemiologic study
por: Wurm, Raphael, et al.
Publicado: (2020)

National Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United States
por: Jairam, Vikram, et al.
Publicado: (2020)

Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes
por: Felício, João S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_62k05f3qv6savm89qv5j05mskr